Welcome to our dedicated page for Ranpak Holdings SEC filings (Ticker: PACK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Searching Ranpak Holdings Corp’s filings usually means wading through pages of paper-pricing tables, equipment placement metrics, and sustainability claims. Investors want quick answers—whether insiders are buying stock ahead of automation rollouts or how e-commerce demand flows into consumable revenue. That’s exactly what our Ranpak SEC page delivers.
Every document, from a Ranpak quarterly earnings report 10-Q filing to a sudden Ranpak 8-K material events explained, lands here moments after EDGAR posts it. Stock Titan’s AI reads the fine print for you, turning dense accounting notes into plain-language highlights. With Ranpak insider trading Form 4 transactions and Ranpak Form 4 insider transactions real-time alerts, you’ll spot executive stock moves alongside our succinct context—why the trade matters for paper volume forecasts or automation cap-ex cycles.
Need deeper perspective? Our platform links each filing type to the questions professionals ask most. The Ranpak annual report 10-K simplified section distills segment growth, pulp cost sensitivity, and ESG metrics. The proxy corner covers Ranpak proxy statement executive compensation, revealing how management bonuses align with eco-innovation goals. For fast trend checks, tap “understanding Ranpak SEC documents with AI” to skim our auto-generated dashboards. Practical use cases include benchmarking pulp input costs across years, monitoring Ranpak executive stock transactions Form 4, and running a Ranpak earnings report filing analysis without opening a single PDF. Bottom line: complex disclosures are translated into clear, actionable insights—all in one place.
Ranpak Holdings Corp. (PACK) – Director share acquisition reported on Form 4
Director Alicia M. Tranen elected to receive her 2025 Q2 board retainer in equity, resulting in the issuance of 5,179 Class A common shares on 07/01/2025 at an implied price of $3.62 per share. Following the transaction, Tranen directly owns 291,300 shares. In addition, she reports 451,584 indirect shares held through the Blue Parrot Trust (71,660) and family accounts (father, spouse, three children). No derivative securities were reported.
The filing highlights continued insider alignment, as the director opted for stock rather than cash compensation, modestly increasing her economic exposure without any accompanying sales. There are no changes to previously reported indirect holdings and no indication of option exercises or other derivative activity.
Form 4 highlights: Director Lynne Marie Sullivan reports the disposition of employee stock options in connection with the closing of Inozyme Pharma, Inc.’s merger with BioMarin Pharmaceutical Inc. on 1 July 2025. The filing confirms that Incline Merger Sub, a wholly-owned subsidiary of BioMarin, merged with and into Inozyme after completing a cash tender offer for all outstanding common shares at $4.00 per share.
Key transaction details
- Derivative security: Stock option (right to buy) covering 28,368 INZY common shares.
- Exercise price: $2.77 per share.
- Form 4 code: “D” (disposition) — the option was cancelled and converted to cash.
- Cash received: For each share underlying the option, the holder receives the difference between the $4.00 merger consideration and the $2.77 exercise price, subject to withholding.
- Post-transaction holdings: 0 derivative securities remain; reporting person has no disclosed direct or indirect ownership of options after the merger.
Merger mechanics: Under the Merger Agreement dated 16 May 2025, all company options with exercise prices below $4.00 automatically vested, were cancelled at closing and exchanged for cash. Inozyme now operates as a wholly-owned subsidiary of BioMarin.
Investor takeaway: The filing is administrative, documenting option cash-out terms already embedded in the merger. Public shareholders will likewise receive $4.00 per share in cash; INZY stock will cease to trade independently.
Ranpak Holdings Corp. (PACK) – Form 4 filing: Director Michael Anthony Jones reported the acquisition of 5,179 Class A common shares on 01 July 2025. The shares, valued at $3.62 each, were issued in lieu of the director’s quarterly cash retainer, resulting in no out-of-pocket purchase by the insider. Following the transaction, Jones’ direct ownership increased to 261,792 shares. No derivative securities were involved and the filing discloses no sales. The transaction is routine compensation-related and does not materially alter Ranpak’s share count or insider ownership structure.
Ranpak Holdings Corp. (NYSE: PACK) filed an 8-K announcing several executive changes.
Appointment of COO: The Board appointed Paul Aram (64) as Chief Operating Officer, effective upon his start date (to be mutually agreed). Aram joins from IDEX Corp., where he was Global Supply Chain & Operations Director (Jan-2024‒Present) and previously served as VP Global Operations at Ingersoll Rand (2019-2023). Key compensation terms include:
- Annual base salary: €310,000
- Target cash bonus: 40 % of base salary
- One-time equity grant: 5,000 PRSUs + 5,000 RSUs
The employment agreement (Exhibit 10.1) allows for future salary/bonus review and standard senior-executive benefits.
Departures of Regional Managing Directors:
- Eric Laurensse, Managing Director – Europe, will depart 1 Aug 2025.
- Antonio Grassotti, Managing Director – APAC, will depart 31 Jul 2025.
Both executives signed separation agreements (Exhibits 10.2 & 10.3). Their outstanding equity awards will continue to vest:
- Laurensse: 76,641 RSUs scheduled to vest in 2026
- Grassotti: 49,965 RSUs scheduled to vest in 2026
The company states there are no disagreements concerning operations, policies, or practices related to these departures.
Investor implications: The hiring of an experienced operations leader may strengthen global supply-chain efficiency, but simultaneous exits of two regional heads introduce transition risk in EMEA and APAC markets. No immediate financial guidance or earnings impact was disclosed.
FAQ
What is the current stock price of Ranpak Holdings (PACK)?
What is the market cap of Ranpak Holdings (PACK)?
What does Ranpak Holdings Corp specialize in?
How does Ranpak generate revenue?
Who are typical customers of Ranpak?
What makes Ranpak's packaging solutions unique?
How does Ranpak maintain its market position?
How is automation incorporated in Ranpak's operations?
What regions does Ranpak serve?
